Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.
Histopathologic study of human breast biopsy samples has identified specific lesions which are associated with a high risk of development of invasive breast cancer. Presumably, these lesions (collectively termed premalignant breast disease) represent the earliest recognizable morphologic expression of fundamental molecular events that lead to the development of invasive breast cancer. To study molecular events underlying premalignant breast disease, we have developed a method for isolating RNA from histologically identified lesions from frozen human breast tissue. This method specifically obtains mRNA from breast epithelial cells and has identified three genes which are differentially expressed in premalignant breast epithelial lesions. One gene identified by this method is overexpressed in four of five noncomedo ductal carcinoma in situ lesions and appears to be the human homologue of the gene encoding the M2 subunit of ribonucleotide reductase, an enzyme involved in DNA synthesis.
Jensen
R A
RA
Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Page
D L
DL
Holt
J T
JT
D001483:Base Sequence; D001706:Biopsy; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000235:genetics / Q000473:pathology; D003001:Cloning, Molecular / Q000379:methods*; D017931:DNA Primers; D018076:DNA, Complementary; D005260:Female; D005348:Fibrocystic Breast Disease; D006801:Humans; D008853:Microscopy / Q000379:methods; D008969:Molecular Sequence Data; D009361:Neoplasm Invasiveness; D011230:Precancerous Conditions / Q000235:genetics* / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis
D017931:DNA Primers; D018076:DNA, Complementary; D012333:RNA, Messenger